ProPhase Labs Correlations
| PRPH Stock | USD 0.26 0.05 23.81% |
The current 90-days correlation between ProPhase Labs and Co Diagnostics is -0.02 (i.e., Good diversification). The correlation of ProPhase Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
ProPhase Labs Correlation With Market
Pay attention - limited upside
The correlation between ProPhase Labs and DJI is -0.74 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ProPhase Labs and DJI in the same portfolio, assuming nothing else is changed.
Moving together with ProPhase Stock
| 0.85 | LFST | Lifeist Wellness | PairCorr |
| 0.75 | SNY | Sanofi ADR Earnings Call This Week | PairCorr |
| 0.75 | 000813 | Dezhan HealthCare | PairCorr |
| 0.76 | 688276 | Changchun BCHT Biote | PairCorr |
| 0.78 | 688185 | Cansino Biologics | PairCorr |
| 0.65 | EXL | Elixinol Wellness | PairCorr |
| 0.87 | 600079 | Humanwell Healthcare | PairCorr |
| 0.81 | FUM | Futura Medical | PairCorr |
| 0.81 | VIT | Vitura Health | PairCorr |
| 0.74 | MVP | Medical Developments | PairCorr |
| 0.65 | ASRT | Assertio Therapeutics | PairCorr |
| 0.8 | DHB | Delivra Health Brands | PairCorr |
| 0.84 | GLABF | Gemina Laboratories | PairCorr |
| 0.89 | ZTLLF | Zonetail | PairCorr |
| 0.75 | NSFDF | NXT Energy Solutions | PairCorr |
Moving against ProPhase Stock
| 0.94 | BMY | Bristol Myers Squibb | PairCorr |
| 0.92 | MRK | Merck Company | PairCorr |
| 0.9 | GSK | GlaxoSmithKline PLC ADR | PairCorr |
| 0.87 | EAH | Eco Animal Health | PairCorr |
| 0.86 | JNJ | Johnson Johnson | PairCorr |
| 0.86 | TBPH | Theravance Biopharma | PairCorr |
| 0.74 | DHT-U | DRI Healthcare Trust | PairCorr |
| 0.68 | EPN | Epsilon Healthcare | PairCorr |
| 0.66 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
| 0.57 | BHC | Bausch Health Companies | PairCorr |
| 0.39 | NVO | Novo Nordisk AS Aggressive Push | PairCorr |
| 0.91 | AIZ | Assurant | PairCorr |
| 0.89 | KEYS | Keysight Technologies | PairCorr |
| 0.87 | HLT | Hilton Worldwide Holdings | PairCorr |
| 0.87 | C | Citigroup | PairCorr |
| 0.86 | AAL | American Airlines Earnings Call This Week | PairCorr |
| 0.86 | ABEV | Ambev SA ADR Aggressive Push | PairCorr |
| 0.85 | FIVE | Five Below | PairCorr |
| 0.84 | IDYA | Ideaya Biosciences | PairCorr |
| 0.83 | KGC | Kinross Gold Aggressive Push | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ProPhase Stock performing well and ProPhase Labs Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ProPhase Labs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AYTU | 2.52 | 0.19 | 0.05 | 0.43 | 3.10 | 4.69 | 12.75 | |||
| TXMD | 4.69 | 1.37 | 0.23 | 1.04 | 5.24 | 13.33 | 43.93 | |||
| ALUR | 5.16 | (0.66) | 0.00 | (0.08) | 0.00 | 16.54 | 40.95 | |||
| ERNA | 4.72 | 0.05 | 0.02 | 0.10 | 4.73 | 12.10 | 51.97 | |||
| BFRI | 3.81 | 0.01 | 0.02 | 0.07 | 4.83 | 9.59 | 32.71 | |||
| ADAP | 12.64 | 0.24 | 0.03 | 0.12 | 15.04 | 22.82 | 168.52 | |||
| AEMD | 5.67 | (0.57) | 0.00 | (0.95) | 0.00 | 10.51 | 38.52 | |||
| CODX | 11.61 | 0.82 | 0.08 | 0.18 | 13.88 | 13.38 | 319.85 | |||
| LNAI | 6.37 | (0.07) | 0.00 | 0.35 | 0.00 | 12.62 | 55.92 | |||
| SBFM | 2.23 | (0.76) | 0.00 | (0.39) | 0.00 | 4.73 | 13.93 |
ProPhase Labs Corporate Management
| Billy White | Consultant | Profile | |
| Stu Hollenshead | Chief Officer | Profile | |
| Sergio Miralles | Executive Diagnostics | Profile | |
| Steven CPA | Chief Officer | Profile | |
| Kevin Quinn | Chief Genomics | Profile |